News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Precision Therapeutics, Inc. Presents GeneFx®Colon Signature at the American Society of Colon and Rectal Surgery Symposium (ASCRS), the World's Largest Colorectal Conference


6/7/2012 11:21:23 AM

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics, a life-science company known for its expertise in the science of personalizing cancer therapy, continues to advance in genomic testing and bioinformatics research. Precision Therapeutics recently added the GeneFx® Colon signature to its array of services to complement Comprehensive Tumor Profiling for stage II colon cancer, and presented data on the test at the American Society of Colon and Rectal Surgery Symposium (ASCRS) June 2-6, 2012 in San Antonio, Texas.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES